← All trials
NCT05869565
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2023
- Primary completion
- Feb 28, 2024
- Completion date
- Mar 31, 2024
- First posted
- May 22, 2023
- Last posted
- May 22, 2023
- Enrollment
- 80
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Aga Khan UniversityLead sponsor
- Aga Khan UniversityOverall official - principal investigator
- Aga Khan UniversityReponsible party - principal investigator
- Zeenat Qureshi Stroke InstituteCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.